Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors

[1]  A. Tan,et al.  Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations , 2021, Nature Ecology & Evolution.

[2]  Ray P.S. Han,et al.  ALICE: a hybrid AI paradigm with enhanced connectivity and cybersecurity for a serendipitous encounter with circulating hybrid cells , 2020, Theranostics.

[3]  N. Cherdyntseva,et al.  Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer , 2020, International journal of molecular sciences.

[4]  J. Weiler,et al.  Cell Fusion-Mediated Tissue Regeneration as an Inducer of Polyploidy and Aneuploidy , 2020, International journal of molecular sciences.

[5]  Ashley M. Laughney,et al.  Regenerative lineages and immune-mediated pruning in lung cancer metastasis , 2019, Nature Medicine.

[6]  Guillaume Thibault,et al.  Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis. , 2020, Methods in molecular biology.

[7]  S. Skvortsov,et al.  Cancer stem cells and their unique role in metastatic spread. , 2020, Seminars in cancer biology.

[8]  Hung-Ming Wang,et al.  Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer , 2019, BMC Cancer.

[9]  Joe W. Gray,et al.  RESTORE: Robust intEnSiTy nORmalization mEthod for multiplexed imaging , 2019, Communications Biology.

[10]  M. Wong,et al.  Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers , 2019, Cellular and molecular gastroenterology and hepatology.

[11]  V. Georgoulias,et al.  Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients , 2019, Cells.

[12]  M. Haris,et al.  RAS-mediated oncogenic signaling pathways in human malignancies. , 2019, Seminars in cancer biology.

[13]  Allen W. Zhang,et al.  Cancer stemness, intratumoral heterogeneity, and immune response across cancers , 2018, Proceedings of the National Academy of Sciences.

[14]  T. Graeber,et al.  Re: A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers. , 2019, The Journal of urology.

[15]  Shinji Iizuka,et al.  Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival , 2018, Science Advances.

[16]  Channing J Der,et al.  KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. , 2018, Cold Spring Harbor perspectives in medicine.

[17]  A. Bilancio,et al.  The Androgen Receptor in Breast Cancer , 2018, Front. Endocrinol..

[18]  G. Kaltsas,et al.  Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms. , 2018, Annals of translational medicine.

[19]  Sandro Santagata,et al.  Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes , 2018, eLife.

[20]  E. Denisov,et al.  Heterogeneity of Circulating Tumor Cells in Neoadjuvant Chemotherapy of Breast Cancer , 2018, Molecules.

[21]  S. Shroff,et al.  A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma. , 2018, Journal of gastrointestinal oncology.

[22]  Samuel F. Bakhoum,et al.  Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.

[23]  K. Xie,et al.  The Role of CD44 and Cancer Stem Cells. , 2018, Methods in molecular biology.

[24]  T. Graeber,et al.  Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer , 2018, Annals of Surgical Oncology.

[25]  Tetsuji Yamaguchi,et al.  Circulating tumor cells detected by the expression of cancer stem cell marker CD90 and CD44 in patients with esophageal cancer , 2017 .

[26]  A. Trumpp,et al.  Survival of pancreatic cancer cells lacking KRAS function , 2017, Nature Communications.

[27]  L. Coussens,et al.  Surgical Procedures and Methodology for a Preclinical Murine Model of De Novo Mammary Cancer Metastasis. , 2017, Journal of visualized experiments : JoVE.

[28]  Vahid Azimi,et al.  Deep learning based Nucleus Classification in pancreas histological images , 2017, 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[29]  M. Pitman,et al.  Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations , 2017, Scientific Reports.

[30]  M. Pitman,et al.  Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations , 2017, Scientific Reports.

[31]  K. Pantel,et al.  Cancer stem cells: The root of tumor recurrence and metastases. , 2017, Seminars in cancer biology.

[32]  Tetsuji Yamaguchi,et al.  Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer , 2016, Oncology letters.

[33]  Claude Preudhomme,et al.  A 17-gene stemness score for rapid determination of risk in acute leukaemia , 2016, Nature.

[34]  T. Fehm,et al.  Gene expression profiling of single circulating tumor cells in ovarian cancer – Establishment of a multi‐marker gene panel , 2016, Molecular oncology.

[35]  Xianjun Yu,et al.  Critical role of oncogenic KRAS in pancreatic cancer (Review). , 2016, Molecular medicine reports.

[36]  T. Whiteside.  Tumor-Derived Exosomes and Their Role in Cancer Progression. , 2016, Advances in clinical chemistry.

[37]  D. Wei,et al.  Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target , 2015, Stem cells translational medicine.

[38]  A. Stenzinger,et al.  Allelic ratio of KRAS mutations in pancreatic cancer. , 2015, The oncologist.

[39]  Nawwaf S. Basakran.  CD44 as a potential diagnostic tumor marker , 2015, Saudi medical journal.

[40]  Robert B Livingston,et al.  Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  A. Iafrate,et al.  Brain tumor cells in circulation are enriched for mesenchymal gene expression. , 2014, Cancer discovery.

[42]  M. Speicher,et al.  Hematogenous dissemination of glioblastoma multiforme , 2014, Science Translational Medicine.

[43]  M. Biffoni,et al.  CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. , 2014, Cell stem cell.

[44]  Lincoln D. Stein,et al.  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.

[45]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[46]  S. Gautam,et al.  The natural history of extracranial metastasis from glioblastoma multiforme , 2011, Journal of Neuro-Oncology.

[47]  Caroline Dive,et al.  Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[49]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[50]  M. Wong,et al.  Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. , 2011, Cancer research.

[51]  Justin C. Grindley,et al.  Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.

[52]  M. Wong,et al.  Inflammation and Proliferation Act Together to Mediate Intestinal Cell Fusion , 2009, PloS one.

[53]  Michael Morse,et al.  Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  Glenn Heller,et al.  Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer , 2007, Clinical Cancer Research.

[55]  M. Clarke,et al.  Cancer stem cells: models and concepts. , 2007, Annual review of medicine.

[56]  J. Massagué,et al.  Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.

[57]  A. Rizvi,et al.  Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Max S Wicha,et al.  Cancer stem cells: an old idea--a paradigm shift. , 2006, Cancer research.

[59]  G. Collins.  The next generation. , 2006, Scientific American.

[60]  J. Long,et al.  Genetic and spectrally distinct in vivo imaging: embryonic stem cells and mice with widespread expression of a monomeric red fluorescent protein , 2005, BMC biotechnology.

[61]  Maria Athelogou,et al.  Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  Cynthia D. Belar,et al.  Models and Concepts , 2005 .

[63]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[64]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[65]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[66]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  P. Ascierto,et al.  Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  A. Vignery,et al.  Osteoclasts and giant cells: macrophage–macrophage fusion mechanism , 2000, International journal of experimental pathology.

[69]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.

[70]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.